Dyne Therapeutics Inc
DYN
$19.19-5.51%
End of day · as of Sep 9, 2026, 10:45 PM ET
Mkt cap
$1.19B
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-1.81
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
1.16
Div yield
N/A
Sector
Healthcare
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
Use this DYN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DYN income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Dyne Therapeutics Inc (DYN) is a biotechnology company in the Healthcare sector.
Latest cached Dyne Therapeutics Inc (DYN) net income for FY2025 was -$446.2M. Statements: https://lician.com/financials/dyn
Dyne Therapeutics Inc (DYN) market capitalization is $1.19B on the latest cached snapshot.
Dyne Therapeutics Inc (DYN) cached previous close $20.31; day range $18.97 – $20.16; volume 5,142,282. Session quote: https://lician.com/quote/dyn
Dyne Therapeutics Inc (DYN) latest cached earnings event is "DYN earnings" on Jul 29, 2026. Earnings calendar: https://lician.com/earnings
The latest cached DYN filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/dyn